Cancer Research Horizons
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Infinitopes
21 Jan 2026
Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer
Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.
52North
6 Dec 2024
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
Cancer Research Horizons
More venture news
- 29 Apr 2026
DexDex lands a £4m seed round led by Notion Capital to match companies with engineers using an intelligent recruiter
SeedHR - 29 Apr 2026
All3All3 raises a £19m seed round led by RTP Global to automate construction with robotics
SeedProperty - 27 Apr 2026
Ineffable IntelligenceIneffable Intelligence lands over £800m in a seed round led by Sequoia and Lightspeed to develop superintelligence with reinforcement learning
SeedAI
